Clear Rock Advisors LLC Acquires 119 Shares of Humana Inc. (NYSE:HUM)

Clear Rock Advisors LLC boosted its holdings in Humana Inc. (NYSE:HUM) by 2.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,250 shares of the insurance provider’s stock after buying an additional 119 shares during the period. Clear Rock Advisors LLC’s holdings in Humana were worth $1,962,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Pzena Investment Management LLC lifted its stake in shares of Humana by 538.7% in the 2nd quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock valued at $866,250,000 after purchasing an additional 1,955,375 shares during the period. Davis Selected Advisers lifted its stake in Humana by 16.1% in the second quarter. Davis Selected Advisers now owns 2,311,362 shares of the insurance provider’s stock valued at $863,640,000 after buying an additional 321,233 shares during the period. Marshall Wace LLP boosted its holdings in Humana by 118.9% during the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after buying an additional 774,085 shares during the last quarter. Legal & General Group Plc grew its position in shares of Humana by 2.1% during the 2nd quarter. Legal & General Group Plc now owns 1,183,985 shares of the insurance provider’s stock worth $442,396,000 after buying an additional 24,842 shares during the period. Finally, Ontario Teachers Pension Plan Board increased its stake in shares of Humana by 11,647.2% in the 1st quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock valued at $367,342,000 after acquiring an additional 1,050,459 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms recently weighed in on HUM. Morgan Stanley initiated coverage on shares of Humana in a research note on Monday, June 24th. They set an “equal weight” rating and a $374.00 price objective on the stock. Oppenheimer boosted their price target on shares of Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a report on Thursday, August 1st. Truist Financial raised their price objective on Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a research note on Monday, July 15th. Deutsche Bank Aktiengesellschaft boosted their target price on Humana from $341.00 to $349.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Finally, TD Cowen increased their price target on Humana from $396.00 to $407.00 and gave the stock a “buy” rating in a report on Wednesday, July 24th. Thirteen research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $398.70.

Humana Price Performance

NYSE:HUM opened at $279.42 on Wednesday. Humana Inc. has a 52-week low of $276.80 and a 52-week high of $530.54. The company has a market cap of $33.67 billion, a P/E ratio of 17.40, a P/E/G ratio of 2.44 and a beta of 0.50. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66. The stock’s 50-day simple moving average is $346.44 and its 200 day simple moving average is $343.73.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The company had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. During the same quarter in the prior year, the business posted $8.94 EPS. The business’s revenue was up 10.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Humana Inc. will post 16.01 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be issued a $0.885 dividend. The ex-dividend date is Monday, September 30th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.27%. Humana’s payout ratio is 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.